Search

Due to an error, Dr. Caitlin D’Amico was mistakenly included as author in this article, published in 2020 in Oncology Reviews (DOI: 10.4081/oncol.2020.429 - PMCID: PMC7036708 - PMID: 32153725), and then retracted (DOI: 10.4081/oncol.2020.493 - PMCID: PMC7196932 - PMID: 32391127). The correct authorship appears above.

The main role of amniotic membrane (AM), or amnion, is to protect the fetus from drying out and create an appropriate environment for its growth. AM is also a suitable candidate for the treatment of various diseases due to its unique characteristics. In recent years, a new line of research has focused on the anticancer properties of amnion and its potential use in cancer treatment. The in vitro and in vivo studies indicate the anti-proliferative and proapoptotic activities, as well as the angioregulatory and immunomodulatory properties of the amniotic membrane. However, the exact mechanism and molecular basis of these anticancer effects of AM are not fully elucidated. This paper presents an overview of the latest findings and knowledge about the anticancer effects of AM and its underlying molecular mechanisms, which is crucial for the application of amnion in cancer therapy.